mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.51 |
4e-05 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |